Disposition, n (%) | Axitinib Titration n = 56 | Placebo Titration n = 56 |
---|---|---|
Discontinued treatment | 47 (84) | 55 (98) |
Disease progression/relapse | 35 (63) | 40 (71) |
Adverse event | 8 (14) | 5 (9) |
Death | 2 (4) | 1 (2) |
Refusal of treatment for reason other than adverse event | 1 (2) | 4 (7) |
Global deterioration in health status | 1 (2) | 1 (2) |
Protocol violation | 0 | 1 (2) |
Other | 0 | 3 (5) |
Remaining on treatment | 9 (16) | 1 (2) |